acetylcysteine has been researched along with Dwarfism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bourmaud, M; Capulli, M; Cohen-Solal, M; Forlino, A; Gramegna Tota, C; Maurizi, A; Monti, I; Monti, L; Paganini, C; Rossi, A; Superti-Furga, A; Teti, A; Villani, S | 1 |
| Chiesa, E; Conti, B; Dorati, R; Genta, I; Modena, T; Monti, L; Paganini, C; Rossi, A | 1 |
| Cohen-Solal, M; De Leonardis, F; Forlino, A; Hay, E; Lecci, S; Monti, L; Paganini, C; Rossi, A; Superti-Furga, A; Tenni, R; Villani, S | 1 |
3 other study(ies) available for acetylcysteine and Dwarfism
| Article | Year |
|---|---|
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine.
Topics: Acetylcysteine; Animals; Animals, Newborn; Bone Density; Disease Models, Animal; Dwarfism; Free Radical Scavengers; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Phenotype | 2021 |
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia.
Topics: Acetylcysteine; Animals; Drug Carriers; Dwarfism; Mice; Mice, Inbred C57BL; Nanoparticles; Off-Label Use; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Tissue Distribution | 2017 |
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia.
Topics: Acetylcysteine; Animals; Animals, Newborn; Antioxidants; Bone and Bones; Cell Proliferation; Chondrocytes; Disease Models, Animal; Dwarfism; Embryo, Mammalian; Female; Growth and Development; Humans; Male; Mice; Pregnancy; Proteoglycans | 2015 |